↓ Skip to main content

PD-1 Receptor (+) T cells are associated with the efficacy of the combined treatment with regulatory t cells and rituximab in type 1 diabetes children via regulatory t cells suppressive activity…

Overview of attention for article published in International Immunopharmacology, March 2024
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#6 of 4,523)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news
44 news outlets

Readers on

mendeley
1 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
PD-1 Receptor (+) T cells are associated with the efficacy of the combined treatment with regulatory t cells and rituximab in type 1 diabetes children via regulatory t cells suppressive activity amelioration
Published in
International Immunopharmacology, March 2024
DOI 10.1016/j.intimp.2024.111919
Pubmed ID
Authors

Maciej Zieliński, Justyna Sakowska, Dorota Iwaszkiewicz-Grześ, Mateusz Gliwiński, Matylda Hennig, Magdalena Żalińska, Anna Wołoszyn-Durkiewicz, Anna Jaźwińska-Curyłło, Halla Kamińska, Radosław Owczuk, Wojciech Młynarski, Przemysława Jarosz-Chobot, Artur Bossowski, Agnieszka Szadkowska, Wojciech Fendler, Iwona Beń-Skowronek, Agata Chobot, Małgorzata Myśliwiec, Janusz Siebert, Natalia Marek-Trzonkowska, Piotr Trzonkowski

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 1 Mendeley reader of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 1 100%

Demographic breakdown

Readers by professional status Count As %
Student > Doctoral Student 1 100%
Readers by discipline Count As %
Engineering 1 100%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 310. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 April 2024.
All research outputs
#111,322
of 25,637,545 outputs
Outputs from International Immunopharmacology
#6
of 4,523 outputs
Outputs of similar age
#714
of 178,965 outputs
Outputs of similar age from International Immunopharmacology
#1
of 33 outputs
Altmetric has tracked 25,637,545 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,523 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.5. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 178,965 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 33 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.